XML 40 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (17,839,057) $ (45,021,027)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of debt discount 333,939
Amortization of capitalized software 5,424,810 2,681,807
Amortization of intangibles 971,464 926,542
Accretion of consideration payable 167,221 273,822
Depreciation of fixed assets 203,952 161,885
Write-down of inventory 537,685 103,417
Sales return reserve 338,193
Loss (gain) on debt extinguishment 325,198 (63,400)
Change in fair value of contingent consideration (5,101,000)
Goodwill and intangible asset impairment charges 8,862,596
Deferred income tax provision 354,000
Operating lease payments 766,280 546,439
Stock issued for legal settlement 532,000 816,000
Stock compensation expense 12,489,343 13,734,614
Changes in Assets and Liabilities    
Accounts receivable (2,442,500) (2,192,888)
Product deposit (358,585) 76,291
Inventory 405,746 (2,183,012)
Other current assets (247,488) 106,168
Change in operating lease liability (808,368) (455,805)
Deferred revenue 3,281,092 4,047,626
Accounts payable 978,062 1,251,037
Accrued expenses 4,678,757 (1,309,968)
Other operating activity (579,319) (888,486)
Net cash provided by (used in) operating activities 8,820,232 (22,935,149)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for capitalized software costs (8,380,602) (8,526,205)
Purchase of equipment (203,814) (366,633)
Purchase of intangible assets (148,868) (4,000,500)
Acquisition of business, net of cash acquired (1,012,395)
Net cash used in investing activities (8,733,284) (13,905,733)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net 19,466,887
Cash proceeds from common stock issued to Medifast 10,000,000
Proceeds from notes payable 2,347,691 2,906,000
Sale of common stock under ATM, net 6,202,659
Cash proceeds from exercise of warrants 38,500
Cash proceeds from exercise of options 94,500 90,400
Preferred stock dividends (3,106,250) (3,106,250)
Net payments for membership interest in WorkSimpli (305,625) 12,150
Contingent consideration payments for ResumeBuild acquisition (312,500) (156,250)
Distributions to non-controlling interest (144,000) (144,000)
Repayment of notes payable, net of prepayment penalty (5,142,542) (168,750)
Net cash provided by (used in) financing activities 29,100,820 (528,200)
Net increase (decrease) in cash 29,187,768 (37,369,082)
Cash at beginning of year 3,958,957 41,328,039
Cash at end of year 33,146,725 3,958,957
Cash paid for interest    
Cash paid during the period for interest 2,148,454 189,000
Non-cash investing and financing activities    
Cashless exercise of options 744 297
Cashless exercise of warrants 793
Consideration payable for Cleared acquisition 8,079,367
Consideration payable for ResumeBuild acquisition 500,000
Stock issued for noncontingent consideration payments 2,568,000
Stock issued for debt conversion 1,000,000
Series B Preferred Stock conversion 5,072,814
Principal of Paycheck Protection Program loans forgiven 63,400
Warrants issued for debt instruments 873,100
Right of use asset 155,168 89,595
Right of use lease liability $ 155,168 $ 94,168